NUVECTIS PHARMA INC (NVCT)
US67080T1088 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -19.37M | -22.26M | -19.09M | -12.89M | 10.00K | |||
| Change In Working Capital | 804.00K | 1.60M | 3.82M | 1.49M | -10.00K | |||
| Interest Paid | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Taxes Paid | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Other non cash items | 4.93M | 4.71M | 1.71M | 1.89M | N/A | |||
| OPERATING CASH FLOW | -13.64M | -15.95M | -13.56M | -9.50M | 0.00 | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Other Investing Activity | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| INVESTING CASH FLOW | N/A | N/A | 0.00 | 0.00 | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 8.98M | 16.48M | 31.88M | 15.25M | N/A | |||
| Other Financing Activity | -242.00K | -1.39M | -4.07M | N/A | 0.00 | |||
| FINANCING CASH FLOW | 8.74M | 15.09M | 27.81M | 15.25M | 0.00 | |||
| CHANGE IN CASH | -4.89M | -867.00K | 14.25M | 5.75M | 0.00 | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -13.64M | -15.95M | -13.56M | -9.50M | 0.00 | |||
| FREE CASH FLOW | -13.64M | -15.95M | -13.56M | -9.50M | 0.00 | |||
All data in USD